Exopharm Ltd (EX1)

Sydney
0.070
0.000(0.00%)
  • Volume:
    12,553
  • Bid/Ask:
    0.070/0.075
  • Day's Range:
    0.070 - 0.070

EX1 Overview

Prev. Close
0.07
Day's Range
0.07-0.07
Revenue
2.08M
Open
0.07
52 wk Range
0.058-0.485
EPS
-0.064
Volume
12,553
Market Cap
11M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
132,473
P/E Ratio
-1.09
Beta
1.41
1-Year Change
-83.72%
Shares Outstanding
157,211,533
Next Earnings Date
-
What is your sentiment on Exopharm?
or
Market is currently closed. Voting is open during market hours.

Exopharm Ltd News

Exopharm Ltd Analysis

Exopharm Ltd Company Profile

Exopharm Ltd Company Profile

Exopharm Limited, a clinical-stage biopharmaceutical company, develops transformative medicines based upon exosomes or extracellular vesicles (EVs) in Australia. The company’s technology includes extracellular vesicle positioning system that allows specific molecules to be attached to the surface of exosomes to target them to selected tissues, organs, or cell types; LOAD technology platform enables loading active pharmaceutical ingredients into exosomes; and ligand-based exosome affinity purification technology solves the critical bottleneck of exosome isolation and purification. Its engineered EVs medicines are applied in the areas, such as neurology, cardiology, and oncology. Exopharm Limited has research collaboration agreements with Astellas Institute for Regenerative Medicine and Showa Denko Materials Co., Ltd. The company was incorporated in 2013 and is based in Melbourne, Australia.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyBuySellStrong Sell
Technical IndicatorsBuyBuyNeutralNeutralStrong Sell
SummaryBuyBuyNeutralNeutralStrong Sell